tradingkey.logo

BRIEF-Nexalin Technology Announces UCSD IRB Approval For Use Of HALO Clarity In Clinical Trials For mTBI And PTSD Treatment

ReutersFeb 18, 2025 2:58 PM

- Nexalin Technology Inc NXL.O:

  • NEXALIN TECHNOLOGY ANNOUNCES UCSD IRB APPROVAL FOR USE OF HALO™ CLARITY IN CLINICAL TRIALS FOR MTBI AND PTSD TREATMENT

Source text: ID:nGNX3pt1ml

Further company coverage: NXL.O

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI